GILD-GILEAD SCIENCES INC-Selling at 83.00 right at the 52 week low. Cap is at 119.62. P/E is at 7.6. Short interest is at 1.61. Dividend is at 1.72 per shrare annualized…but it does look like they just started their dividend in 2015. EPS is 10.92 and thus dividend is at about 16% of EPS. Analysts are very bullish. Book value is at 12.02. Enterprise value is at 126b. Book per share is at 19.36 growth. EPS this year is supposed ot be slightly negative, but then 14.69 growht over next 5. Return on equity is at 102%. Debt is at 86%. Earnings growth kinda goes up and down year to year, but compounds at an insane 28%. These guys are a biotech firm under political scrutiny due to their prices. If they don’t get crushed by some kind of new regulation, they’ll pretty clearly be a buy, but let’s see, return on equity will be at like 30 historically. Book grows at an insane 20% over the last 10. So let’s say book grows at 15%, we’d have book of 48.63, and thus EPS of 14.589 and thus a share price of 116 using an 8 p/e. I’m giving this company pretty much every opportunity to suck and in the worst case scenario I think it will work out, but let’s say they continue on their trajectory. We could see book of 74.42, and thus EPS of say 37.21 with a .5 r on e. and with a 15 p/e we could see a price of say, 558.15. That’s a monster 20.99 return. If they came down to 70, I’d take a position. There is a lot of speculative growth potential, but their are powerful forces at work here.
USB-US BANCORP-Selling at 40. The 52 week low is at 37.97. Dividend is at 1 per year. P/E is at 12.64 and EPS is at 3.16, and thus dividends are 32% of EPS. Short interest is at .79%. Analysts are bearish. Earnings are pretty good, but they are a bank and so they suffered during the recession. 70b in cap. Book is at 26.44. Forward EPS is at 7.99 growth. 5.4 in next 3-5 years. Book growth is at 8% over last 5. Return on equity is at 14. Debt is at 83.51. Return on equity is always at like 13. Book grows at a very consistent 8%. So let’s say book is at 57.08. Let’s say that dividend is at 10 with ten and tax. We could see EPS of say 7.42 and with a p/e of 12, we could see a price of say 94 plus the ten for a value of 104. That’s a pretty great 10% return. I see why buffett likes these guys. They are gonna be a great stock, but they are only gonna compound at like 10. I’d buy for 25 and hold for life. I’ll by at 32 because they are so good.
CVS-CVS HEALTH CORPORATION-Selling at 96.59. Cap is at 106.96b. Short interest is at 1.39. P/E is at 21.8. Dividend is at 1.7. EPS is at 4.43 and thus dividend is at 38% of earnings. Analysts are bullish. Book is at 33.49. P/E average is at 18.08. Earnings are projected to grow at 12.77 and 14.41 over next3-5. Book only grew at 1.2% this year? Return on equity is at 13.54 this year. Debt is at 41.4. Earnings have been growing very well. Earnings grew at 12.66 over the past 10…wow. Book has been growing at a fantastic pace. Book has grown at 12.83 in the past 10. Return on equity is at about 12 average. So let’s say book is at 104.01 in 10, and so with r on e of 12, we could see EPS of 12.48 and with an average p/e of 18, we could see a price of 224.64 plus dividends of say 15, we’ll call it 240. That’s a 9.53% return. My entry point is at 75.
TSQ-TOWNSQUARE MEDIA INC-Sells at 9.4. Selling near their 52 week low. No dividend. P/E is at 25.41. .8% short interest. Cap is at 167.87m. Analysts are kinda neutral. Book is at 20.20. No earnings estimates. No EPS growth estimates. Return on equity is at 3.6%? Debt to equity is at 162.99. These guys have very spotty earnings growth. Na. This is speculative stuff that some guy in Barron’s suggested.